Gene Activity List

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

eRecord

Gene Compound Experiment Study Pathway Assay Report Bug Request Feature

Gene Activity List

You are on Page 99 of 1714:

89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109

Gene	Compound	Assay	Inh	Ic50	Ki	View

cannabinoid receptor 1 (brain)	OXICONAZOLE	Cannabinoid CB1	34%	NoneNone	NoneNone	View
adrenergic receptor, alpha 2b	TROXIPIDE	Adrenergic alpha2B	34%	NoneNone	NoneNone	View
dopamine receptor D1A	OXYBUTYNIN	Dopamine D1	34%	NoneNone	NoneNone	View
adrenergic receptor, beta 3	SODIUM ORTHOVANADATE	Adrenergic beta3	34%	NoneNone	NoneNone	View
Protein-tyrosine kinase, Fyn	PROBUCOL	Protein Tyrosine Kinase, Fyn	34%	NoneNone	NoneNone	View
leukotriene C4 synthase	PRIMAQUINE	Leukotriene C4 Synthetase	34%	NoneNone	NoneNone	View
leukotriene C4 synthase	PRIMAQUINE	Leukotriene C4 Synthetase	34%	NoneNone	NoneNone	View
dopamine receptor D1A	RABEPRAZOLE	Dopamine D1	34%	NoneNone	NoneNone	View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase)	GENACONAZOLE (RR(+) ISOMER)	CYP450-2C9 Inhibition	34%	NoneNone	NoneNone	View
cytochrome P450, family 2, subfamily C, polypeptide 9	GENACONAZOLE (RR(+) ISOMER)	CYP450-2C9 Inhibition	34%	NoneNone	NoneNone	View
adrenergic receptor, beta 3	ALFACALCIDOL	Adrenergic beta3	34%	NoneNone	NoneNone	View
platelet derived growth factor receptor, alpha polypeptide	STANOZOLOL	Platelet-Derived Growth Factor (PDGF)	34%	NoneNone	NoneNone	View
platelet-derived growth factor receptor, alpha polypeptide	STANOZOLOL	Platelet-Derived Growth Factor (PDGF)	34%	NoneNone	NoneNone	View
platelet derived growth factor receptor, beta polypeptide	STANOZOLOL	Platelet-Derived Growth Factor (PDGF)	34%	NoneNone	NoneNone	View
platelet-derived growth factor receptor, beta polypeptide	STANOZOLOL	Platelet-Derived Growth Factor (PDGF)	34%	NoneNone	NoneNone	View
Cytochrom P450-2D6 monooxygenase	CETYLPYRIDINIUM BROMIDE	CYP450-2D6 Inhibition	34%	NoneNone	NoneNone	View
androgen receptor	CANDESARTAN	Testosterone	34%	NoneNone	NoneNone	View
opioid receptor, delta 1	BENZETHONIUM CHLORIDE	Opiate delta	34%	NoneNone	NoneNone	View
A3 adenosine receptor	MELPHALAN	Adenosine A3	34%	NoneNone	NoneNone	View
Protein-tyrosine kinase, Fyn	MELPHALAN	Protein Tyrosine Kinase, Fyn	34%	NoneNone	NoneNone	View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase)	NISOLDIPINE	CYP450-2C9 Inhibition	34%	NoneNone	NoneNone	View
cytochrome P450, family 2, subfamily C, polypeptide 9	NISOLDIPINE	CYP450-2C9 Inhibition	34%	NoneNone	NoneNone	View
mitogen activated protein kinase 1	NIMESULIDE	Protein Serine/Threonine Kinase, ERK2	34%	NoneNone	NoneNone	View
mitogen-activated protein kinase 1	NIMESULIDE	Protein Serine/Threonine Kinase, ERK2	34%	NoneNone	NoneNone	View
arachidonate 15-lipoxygenase, second type	SPARFLOXACIN	Lipoxygenase 15-LO	34%	NoneNone	NoneNone	View
arachidonate 15-lipoxygenase	SPARFLOXACIN	Lipoxygenase 15-LO	34%	NoneNone	NoneNone	View
arachidonate 15-lipoxygenase	SPARFLOXACIN	Lipoxygenase 15-LO	34%	NoneNone	NoneNone	View
histamine receptor H 2	AZTREONAM	Histamine H2	34%	NoneNone	NoneNone	View
leukotriene C4 synthase	AZTREONAM	Leukotriene C4 Synthetase	34%	NoneNone	NoneNone	View
leukotriene C4 synthase	AZTREONAM	Leukotriene C4 Synthetase	34%	NoneNone	NoneNone	View
androgen receptor	NISOLDIPINE	Testosterone	34%	NoneNone	NoneNone	View
adrenergic receptor, alpha 1d (Non-specific probe)	BAY 11-7085	Adrenergic alpha1D	34%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type IV, beta	MC 258717	Sodium Channel, Site 2	34%	NoneNone	NoneNone	View
sodium channel associated protein 1	MC 258717	Sodium Channel, Site 2	34%	NoneNone	NoneNone	View
sodium channel associated protein 2	MC 258717	Sodium Channel, Site 2	34%	NoneNone	NoneNone	View
sodium channel, voltage-gated, type III, beta	MC 258717	Sodium Channel, Site 2	34%	NoneNone	NoneNone	View
epidermal growth factor receptor	LOPERAMIDE	Protein Tyrosine Kinase, EGF Receptor	34%	NoneNone	NoneNone	View
adenosine A1 receptor	1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE	Adenosine A1	34%	NoneNone	NoneNone	View
tachykinin receptor 2	LORATADINE	Tachykinin NK2	34%	NoneNone	NoneNone	View
cholinergic receptor, muscarinic 3	LORATADINE	Muscarinic M3	34%	NoneNone	NoneNone	View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2	1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE	Adrenergic, Norepinephrine Transporter	34%	NoneNone	NoneNone	View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2	1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE	Adrenergic, Norepinephrine Transporter	34%	NoneNone	NoneNone	View
phosphodiesterase 5A, cGMP-specific	LEFLUNOMIDE	Phosphodiesterase PDE5	34%	NoneNone	NoneNone	View
phosphodiesterase 5A, cGMP-specific	LEFLUNOMIDE	Phosphodiesterase PDE5	34%	NoneNone	NoneNone	View
Cytochrom P450-2C19 monooxygenase	DIELDRIN	CYP450-2C19 Inhibition	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1D subunit	BISPHENOL A	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1C subunit	BISPHENOL A	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	BISPHENOL A	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 1 subunit	BISPHENOL A	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1E subunit	BISPHENOL A	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, N type, alpha 1B subunit	BISPHENOL A	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, alpha2/delta subunit 1	BISPHENOL A	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
adrenergic receptor, alpha 2b	PHENOTHIAZINE	Adrenergic alpha2B	34%	NoneNone	NoneNone	View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase)	TRIAMCINOLONE	CYP450-2C9 Inhibition	34%	NoneNone	NoneNone	View
cytochrome P450, family 2, subfamily C, polypeptide 9	TRIAMCINOLONE	CYP450-2C9 Inhibition	34%	NoneNone	NoneNone	View
epidermal growth factor receptor	BETA-ESTRADIOL 3-BENZOATE	Protein Tyrosine Kinase, EGF Receptor	34%	NoneNone	NoneNone	View
adenosine A2a receptor	AMILORIDE	Adenosine A2A	34%	NoneNone	NoneNone	View
Cytochrom P450-1A2 monooxygenase	TIRILAZAD	CYP450-1A2 Inhibition	34%	NoneNone	NoneNone	View
adrenergic receptor, alpha 2a	TIRILAZAD	Imidazoline I2, Central	34%	NoneNone	NoneNone	View
adrenergic receptor, alpha 2c (Non-specific probe)	TIRILAZAD	Imidazoline I2, Central	34%	NoneNone	NoneNone	View
aldo-keto reductase family 1, member B4 (aldose reductase)	FLUNOXAPROFEN	Aldose Reductase	34%	NoneNone	NoneNone	View
aldo-keto reductase family 1, member B1 (aldose reductase)	FLUNOXAPROFEN	Aldose Reductase	34%	NoneNone	NoneNone	View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	FLUNOXAPROFEN	Aldose Reductase	34%	NoneNone	NoneNone	View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)	FLUNOXAPROFEN	Aldose Reductase	34%	NoneNone	NoneNone	View
neuropeptide Y receptor Y1	HYDROXYUREA	Neuropeptide Y1	34%	NoneNone	NoneNone	View
interleukin 8 receptor, alpha	AMINOCAPROIC ACID	Chemokine CXCR1(IL-8A)	34%	NoneNone	NoneNone	View
chemokine (C-C motif) receptor 4	ETOPOSIDE	Chemokine CCR4	34%	NoneNone	NoneNone	View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase	2-HYDROXYPROPYL-BETA-CYCLODEXTRIN	Acetylcholinesterase	34%	NoneNone	NoneNone	View
acetylcholinesterase	2-HYDROXYPROPYL-BETA-CYCLODEXTRIN	Acetylcholinesterase	34%	NoneNone	NoneNone	View
acetylcholinesterase (YT blood group)	2-HYDROXYPROPYL-BETA-CYCLODEXTRIN	Acetylcholinesterase	34%	NoneNone	NoneNone	View
Sigma-2 Receptor	PACLITAXEL	Sigma2	34%	NoneNone	NoneNone	View
5-hydroxytryptamine (serotonin) receptor 1B	PACLITAXEL	Serotonin 5-HT1B	34%	NoneNone	NoneNone	View
phosphodiesterase 4A, cAMP specific	2-HYDROXYPROPYL-BETA-CYCLODEXTRIN	Phosphodiesterase PDE4	34%	NoneNone	NoneNone	View
phosphodiesterase 4C, cAMP-specific	2-HYDROXYPROPYL-BETA-CYCLODEXTRIN	Phosphodiesterase PDE4	34%	NoneNone	NoneNone	View
phosphodiesterase 4D	2-HYDROXYPROPYL-BETA-CYCLODEXTRIN	Phosphodiesterase PDE4	34%	NoneNone	NoneNone	View
phosphodiesterase 4B, cAMP specific	2-HYDROXYPROPYL-BETA-CYCLODEXTRIN	Phosphodiesterase PDE4	34%	NoneNone	NoneNone	View
glycine receptor, alpha 3	AMITRIPTYLINE	Glycine, Strychnine-Sensitive	34%	NoneNone	NoneNone	View
glycine receptor, alpha 1 subunit	AMITRIPTYLINE	Glycine, Strychnine-Sensitive	34%	NoneNone	NoneNone	View
glycine receptor, beta subunit	AMITRIPTYLINE	Glycine, Strychnine-Sensitive	34%	NoneNone	NoneNone	View
glycine receptor, alpha 2 subunit	AMITRIPTYLINE	Glycine, Strychnine-Sensitive	34%	NoneNone	NoneNone	View
adrenergic receptor, alpha 2a	U-78517F	Imidazoline I2, Central	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1S subunit	AURANOFIN	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, alpha 1F subunit	AURANOFIN	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1D subunit	AURANOFIN	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1C subunit	AURANOFIN	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	AURANOFIN	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 1 subunit	AURANOFIN	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1E subunit	AURANOFIN	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, N type, alpha 1B subunit	AURANOFIN	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, alpha2/delta subunit 1	AURANOFIN	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
cholinergic receptor, muscarinic 5	DANAZOL	Muscarinic M5	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 8	LY-294002	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 7	LY-294002	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 6	LY-294002	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 5	LY-294002	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 4	LY-294002	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 3	LY-294002	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 2	LY-294002	Calcium Channel Type L, Phenylalkylamine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1D subunit	4-NONYLPHENOL	Calcium Channel Type L, Dihydropyridine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1C subunit	4-NONYLPHENOL	Calcium Channel Type L, Dihydropyridine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	4-NONYLPHENOL	Calcium Channel Type L, Dihydropyridine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 1 subunit	4-NONYLPHENOL	Calcium Channel Type L, Dihydropyridine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1E subunit	4-NONYLPHENOL	Calcium Channel Type L, Dihydropyridine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, N type, alpha 1B subunit	4-NONYLPHENOL	Calcium Channel Type L, Dihydropyridine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, alpha2/delta subunit 1	4-NONYLPHENOL	Calcium Channel Type L, Dihydropyridine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 8	4-NONYLPHENOL	Calcium Channel Type L, Dihydropyridine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 7	4-NONYLPHENOL	Calcium Channel Type L, Dihydropyridine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 6	4-NONYLPHENOL	Calcium Channel Type L, Dihydropyridine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 5	4-NONYLPHENOL	Calcium Channel Type L, Dihydropyridine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 4	4-NONYLPHENOL	Calcium Channel Type L, Dihydropyridine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 3	4-NONYLPHENOL	Calcium Channel Type L, Dihydropyridine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 2	4-NONYLPHENOL	Calcium Channel Type L, Dihydropyridine	34%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 1	4-NONYLPHENOL	Calcium Channel Type L, Dihydropyridine	34%	NoneNone	NoneNone	View
androgen receptor	CADMIUM ACETATE	Testosterone	33%	NoneNone	NoneNone	View
adrenergic receptor, beta 3	CLOBETASOL PROPIONATE	Adrenergic beta3	33%	NoneNone	NoneNone	View
insulin receptor	CLOBETASOL PROPIONATE	Insulin	33%	NoneNone	NoneNone	View
insulin receptor	CLOBETASOL PROPIONATE	Insulin	33%	NoneNone	NoneNone	View
dopamine receptor D4	CLOMIPHENE	Dopamine D4.2	33%	NoneNone	NoneNone	View
5-hydroxytryptamine (serotonin) receptor 1B	GENTAMICIN	Serotonin 5-HT1B	33%	NoneNone	NoneNone	View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase)	FAMOTIDINE	CYP450-2C9 Inhibition	33%	NoneNone	NoneNone	View
cytochrome P450, family 2, subfamily C, polypeptide 9	FAMOTIDINE	CYP450-2C9 Inhibition	33%	NoneNone	NoneNone	View
Cytochrom P450-2C19 monooxygenase	DROPERIDOL	CYP450-2C19 Inhibition	33%	NoneNone	NoneNone	View
leukotriene C4 synthase	OXFENDAZOLE	Leukotriene C4 Synthetase	33%	NoneNone	NoneNone	View
leukotriene C4 synthase	OXFENDAZOLE	Leukotriene C4 Synthetase	33%	NoneNone	NoneNone	View
arginine vasopressin receptor 1A	TRIACETIN	Vasopressin V1A	33%	NoneNone	NoneNone	View
epidermal growth factor receptor	DISULFIRAM	Protein Tyrosine Kinase, EGF Receptor	33%	NoneNone	NoneNone	View
protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform (calcineurin A alpha)	HALOPROGIN	Protein Serine/Threonine Phosphatase, Calcineurin PP2B	33%	NoneNone	NoneNone	View
protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta)	HALOPROGIN	Protein Serine/Threonine Phosphatase, Calcineurin PP2B	33%	NoneNone	NoneNone	View
protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma)	HALOPROGIN	Protein Serine/Threonine Phosphatase, Calcineurin PP2B	33%	NoneNone	NoneNone	View
protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma)	HALOPROGIN	Protein Serine/Threonine Phosphatase, Calcineurin PP2B	33%	NoneNone	NoneNone	View
protein phosphatase 3, catalytic subunit, beta isoform	HALOPROGIN	Protein Serine/Threonine Phosphatase, Calcineurin PP2B	33%	NoneNone	NoneNone	View
bM410K19.2.2 (novel protein similar to extra-cellular matrix proteins and chondroitin sulfate proteoglycans, variant 2) (DBSS)	HALOPROGIN	Protein Serine/Threonine Phosphatase, Calcineurin PP2B	33%	NoneNone	NoneNone	View
opioid receptor, sigma 1	HALOPROGIN	Sigma1	33%	NoneNone	NoneNone	View
mitogen activated protein kinase 3	HALOPROGIN	Protein Serine/Threonine Kinase, ERK1	33%	NoneNone	NoneNone	View
mitogen-activated protein kinase 3	HALOPROGIN	Protein Serine/Threonine Kinase, ERK1	33%	NoneNone	NoneNone	View
Protein-tyrosine kinase, Fyn	AMINOPTERIN	Protein Tyrosine Kinase, Fyn	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 8	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 7	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 6	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 5	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 4	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 3	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 2	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, gamma subunit 1	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 4 subunit	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 3 subunit	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 2 subunit	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1S subunit	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, alpha 1F subunit	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1D subunit	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1C subunit	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, beta 1 subunit	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, L type, alpha 1E subunit	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, N type, alpha 1B subunit	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
calcium channel, voltage-dependent, alpha2/delta subunit 1	TRIOXSALEN	Calcium Channel Type L, Phenylalkylamine	33%	NoneNone	NoneNone	View
histamine receptor H 2	TRIHEXYPHENIDYL	Histamine H2	33%	NoneNone	NoneNone	View
estrogen receptor 1	4-FLUORO-L-PHENYLALANINE	Estrogen ERalpha	33%	NoneNone	NoneNone	View
dopamine receptor 2	OXYMETAZOLINE	Dopamine D2L	33%	NoneNone	NoneNone	View
glutamate receptor, ionotropic, N-methyl D-aspartate 2D	CADMIUM CHLORIDE	Glutamate, NMDA, Agonism	33%	NoneNone	NoneNone	View
glutamate receptor, ionotropic, NMDA2C	CADMIUM CHLORIDE	Glutamate, NMDA, Agonism	33%	NoneNone	NoneNone	View
glutamate receptor, ionotropic, N-methyl D-aspartate 2B	CADMIUM CHLORIDE	Glutamate, NMDA, Agonism	33%	NoneNone	NoneNone	View
glutamate receptor, ionotropic, N-methyl D-aspartate 2A	CADMIUM CHLORIDE	Glutamate, NMDA, Agonism	33%	NoneNone	NoneNone	View
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.)	CADMIUM CHLORIDE	Glutamate, NMDA, Agonism	33%	NoneNone	NoneNone	View
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B	CADMIUM CHLORIDE	Glutamate, NMDA, Agonism	33%	NoneNone	NoneNone	View
Protein-tyrosine kinase, Fyn	ORPHENADRINE	Protein Tyrosine Kinase, Fyn	33%	NoneNone	NoneNone	View
monoamine oxidase A	ACYCLOVIR	Monoamine Oxidase MAOA	33%	NoneNone	NoneNone	View
monoamine oxidase A	ACYCLOVIR	Monoamine Oxidase MAOA	33%	NoneNone	NoneNone	View
5-hydroxytryptamine (serotonin) receptor 1B	PRAMOXINE	Serotonin 5-HT1B	33%	NoneNone	NoneNone	View
purinergic receptor P2X, ligand-gated ion channel, 1	PHENYLHYDRAZINE	Purinergic P2X	33%	NoneNone	NoneNone	View
purinergic receptor P2X, ligand-gated ion channel, 7	PHENYLHYDRAZINE	Purinergic P2X	33%	NoneNone	NoneNone	View
purinergic receptor P2X-like 1, orphan receptor	PHENYLHYDRAZINE	Purinergic P2X	33%	NoneNone	NoneNone	View
Cytochrom P450-2D6 monooxygenase	AMPRENAVIR	CYP450-2D6 Inhibition	33%	NoneNone	NoneNone	View
cholinergic receptor, muscarinic 5	PRIMAQUINE	Muscarinic M5	33%	NoneNone	NoneNone	View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2	PROBUCOL	Adrenergic, Norepinephrine Transporter	33%	NoneNone	NoneNone	View
adrenergic receptor, alpha 1d (Non-specific probe)	PRIMAQUINE	Adrenergic alpha1D	33%	NoneNone	NoneNone	View
chemokine (C-C motif) receptor 2	POLYVINYL ALCOHOL	Chemokine CCR2B	33%	NoneNone	NoneNone	View
Cytochrom P450-1A2 monooxygenase	CANTHARIDIN	CYP450-1A2 Inhibition	33%	NoneNone	NoneNone	View
mu-opioid receptor MOR	PROMETHAZINE	Opiate mu	33%	NoneNone	NoneNone	View
melanocortin 3 receptor	PROCAINAMIDE	Melanocortin MC3	33%	NoneNone	NoneNone	View
melanocortin 3 receptor	PROCAINAMIDE	Melanocortin MC3	33%	NoneNone	NoneNone	View
adrenergic receptor, alpha 2b	SIBUTRAMINE	Adrenergic alpha2C	33%	NoneNone	NoneNone	View
adrenergic receptor, alpha 2c (Non-specific probe)	SIBUTRAMINE	Adrenergic alpha2C	33%	NoneNone	NoneNone	View
leukotriene C4 synthase	PROGLUMIDE	Leukotriene C4 Synthetase	33%	NoneNone	NoneNone	View
leukotriene C4 synthase	PROGLUMIDE	Leukotriene C4 Synthetase	33%	NoneNone	NoneNone	View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3	PODOPHYLLOTOXIN	Adenosine Transporter	33%	NoneNone	NoneNone	View
concentrative Na+ nucleoside cotransporter (DBSS)	PODOPHYLLOTOXIN	Adenosine Transporter	33%	NoneNone	NoneNone	View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1	PODOPHYLLOTOXIN	Adenosine Transporter	33%	NoneNone	NoneNone	View
adenine nucleotide translocase (DBSS) (Non-specific probe)	PODOPHYLLOTOXIN	Adenosine Transporter	33%	NoneNone	NoneNone	View
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4	PODOPHYLLOTOXIN	Adenosine Transporter	33%	NoneNone	NoneNone	View
interleukin 8 receptor, alpha	CHLORDIAZEPOXIDE	Chemokine CXCR1(IL-8A)	33%	NoneNone	NoneNone	View
cholinergic receptor, muscarinic 3	RALOXIFENE	Muscarinic M3	33%	NoneNone	NoneNone	View
cytochrome P450, family 3, subfamily a, polypeptide 13	RALOXIFENE	CYP450-3A4 Inhibition	33%	NoneNone	NoneNone	View
nuclear receptor subfamily 3, group C, member 1	STANOZOLOL	Glucocorticoid	33%	NoneNone	NoneNone	View
cholinergic receptor, muscarinic 4	SIBUTRAMINE	Muscarinic M4	33%	NoneNone	NoneNone	View
prostaglandin-endoperoxide synthase 2	STAVUDINE	Cyclooxygenase COX-2	33%	NoneNone	NoneNone	View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)	STAVUDINE	Cyclooxygenase COX-2	33%	NoneNone	NoneNone	View
5-hydroxytryptamine (serotonin) receptor 5B	PHENTOLAMINE	Serotonin 5-HT4	33%	NoneNone	NoneNone	View
5-hydroxytryptamine (serotonin) receptor 4	PHENTOLAMINE	Serotonin 5-HT4	33%	NoneNone	NoneNone	View
adrenergic receptor, alpha 1d (Non-specific probe)	SB-203580	Adrenergic alpha1D	33%	NoneNone	NoneNone	View